vision changes with tirzepatide Comparative ocular outcomes of versus other anti-obesity medications in people obesity tirzepatide blindness and A small

Carrie Burns , MD, is a board-certified endocrinologist and director of diabetes in pregnancy at Penn Medicine in Philadelphia

Plan for 80120 grams of protein daily unless your care team advises otherwise

Saxenda was the first GLP-1 medication to get approval from the FDA for weight management in adults with obesity and overweight with at least one weight-related health condition as an adjunct to exercise, and lifestyle and dietary modifications

These are questions worth asking before any monthly subscription health commitment

Potential considerations and risks primarily relate to the known effects on diabetic retinopathy rather than AMD specifically

These results come from a controlled clinical trial